Janux Therapeutics (JANX) Interest & Investment Income (2021 - 2026)
Janux Therapeutics (JANX) reported Interest & Investment Income of $9.9 million for Q1 2026, down 13.5% year-over-year from $11.4 million in Q1 2025, and down 5.77% quarter-over-quarter from $10.5 million in Q4 2025.
Janux Therapeutics (JANX) Interest & Investment Income (2021 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has 6 years of Interest & Investment Income data on file, last reported at $9.9 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $9.9 million, down 13.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $42.5 million (up 18.59% YoY), and the FY2025 annual result was $44.0 million, up 47.53% from the prior year.
- Interest & Investment Income declined to $9.9 million in Q1 2026 per JANX's latest filing, from $10.5 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $11.4 million in Q1 2025 and troughed at $132000.0 in Q1 2022.
- A 5-year average of $6.0 million and a median of $5.4 million in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2026: Interest & Investment Income surged 2874.32% in 2022, then decreased 13.5% in 2026.
- A 5-year view of Interest & Investment Income shows it stood at $2.2 million in 2022, then surged by 98.96% to $4.4 million in 2023, then surged by 101.1% to $8.8 million in 2024, then climbed by 18.73% to $10.5 million in 2025, then dropped by 5.77% to $9.9 million in 2026.
- Business Quant data shows JANX's Interest & Investment Income at $9.9 million in Q1 2026, $10.5 million in Q4 2025, and $10.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Janux Therapeutics | 892.99 Mn | 892.99 Mn | - | 9.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.85 Mn |
| Dec 31, 2025 | 10.46 Mn |
| Sep 30, 2025 | 10.94 Mn |
| Jun 30, 2025 | 11.26 Mn |
| Mar 31, 2025 | 11.39 Mn |
| Dec 31, 2024 | 8.81 Mn |
| Sep 30, 2024 | 7.78 Mn |
| Jun 30, 2024 | 7.86 Mn |
| Mar 31, 2024 | 5.40 Mn |
| Dec 31, 2023 | 4.38 Mn |
| Sep 30, 2023 | 4.25 Mn |
| Jun 30, 2023 | 3.24 Mn |
| Mar 31, 2023 | 2.82 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 373,000.00 |
| Mar 31, 2022 | 132,000.00 |
| Dec 31, 2021 | 74,000.00 |
| Sep 30, 2021 | 137,000.00 |
| Jun 30, 2021 | 46,000.00 |